Peginterferon-??-2a (40kD) Plus Ribavirin
- 1 January 2004
- journal article
- Published by Springer Nature in Drugs
- Vol. 64 (24) , 2823-2843
- https://doi.org/10.2165/00003495-200464240-00009
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patientsAIDS, 2004
- Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected PersonsNew England Journal of Medicine, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Update on chronic hepatitis C in HIV/HCV-coinfected patientsAIDS, 2003
- Effect of Ribavirin on Hepatitis C Viral Kinetics in Patients Treated With Pegylated InterferonHepatology, 2003
- Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patientsAIDS, 2003
- Ribavirin inhibits DNA, RNA, and protein synthesis in PHA‐stimulated human peripheral blood mononuclear cells: Possible explanation for therapeutic efficacy in patients with chronic HCV infectionJournal of Medical Virology, 2002
- Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials GroupClinical Infectious Diseases, 2002
- Estimating progression to cirrhosis in chronic hepatitis C virus infectionHepatology, 2001
- Clinical Outcomes after Transfusion-Associated Hepatitis CNew England Journal of Medicine, 1995